title: Mechanisms of biliary carcinogenesis: a pathogenetic multi-stage cascade towards cholangiocarcinoma.
abstract: Carcinomas of the biliary tract are rare cancers developing from the epithelial or blast-like cells lining the bile ducts. A variety of known predisposing factors and recent experimental models of biliary carcinogenesis (e.g., infection with the liver fluke Opisthorchis viverrini, models of chemically induced carcinogenesis and experimental models of pancreaticobiliary maljunction) have elucidated different stages of this complex system of biliary tumorigenesis. Chronic inflammatory processes, generation of active oxygen radicals, altered cellular detoxification mechanisms, activation of oncogenes, functional loss of tumor-suppressor genes and dysregulation of cell proliferation and cell apoptotic mechanisms have been identified as important contributors in the development of cholangiocarcinomas. In this review, the known mechanisms involved in the carcinogenesis of biliary epithelium are addressed. We will divide the topic into four stages: 1) Predisposition and risk factors of biliary cancer. 2) Genotoxic events and alterations leading to specific DNA damage and mutation patterns. 3) Dysregulation of DNA repair mechanisms and apoptosis, permitting survival of mutated cells and 4) Morphological evolution from premalignant biliary lesions to cholangiocarcinoma. Finally, established and hypothetical future therapeutic strategies directed towards specific pathogenetic events during biliary carcinogenesis will be addressed.
authors.affiliation: Department of Visceral and Transplantation Surgery, Inselspital, University of Berne, Switzerland.
authors.forename: F
authors.initials: F
authors.lastname: Holzinger
authors.forename: K
authors.initials: K
authors.lastname: Z'graggen
authors.forename: M W
authors.initials: MW
authors.lastname: Büchler
mesh_terms: D017209:Apoptosis; D001650:Bile Duct Neoplasms / Q000209:etiology* / Q000628:therapy; D001652:Bile Ducts / Q000002:abnormalities; D018281:Cholangiocarcinoma / Q000209:etiology* / Q000628:therapy; D015209:Cholangitis, Sclerosing / Q000150:complications; D002769:Cholelithiasis / Q000150:complications; D004260:DNA Repair; D006801:Humans